ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

Conferees Stalled On Money Bill, Running Out Of Time

September 17, 1976

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

Protest Erupts Over Charge That NCAB Directives On CCOP Are Ignored; “Misunderstanding,” DeVita Says

June 25, 1982